Search results
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 13 hours agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 11 hours agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...
Gateway - Quartz
Quartz· 5 hours agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
Moderna stock is lone omen of bird flu pandemic
Reuters· 14 hours agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 2 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Wellington Management Group LLP
ETF DAILY NEWS· 1 day agoWellington Management Group LLP lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.8% in the 4th quarter, according to the company in its most ...
Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the...
Simply Wall St. via Yahoo Finance· 4 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...